Vitamin K‐dependent gamma‐carboxyglutamic acid protein 1 promotes pancreatic ductal adenocarcinoma progression through stabilizing oncoprotein KRAS and tyrosine kinase receptor EGFR

基因敲除 癌症研究 胰腺癌 化学 生物 分子生物学 医学 内科学 生物化学 癌症 细胞凋亡
作者
Zheng Wu,Qing Ye,Shan Zhang,Longgang Hu,Xiao‐Qi Wang,Linli Yao,Lei Zhu,Shu‐Yu Xiao,Zong‐Hao Duan,Xueli Zhang,Shu‐Heng Jiang,Zhigang Zhang,Dejun Liu,Dong‐Xue Li,Xiao‐Mei Yang
出处
期刊:Clinical and translational medicine [Springer Science+Business Media]
卷期号:15 (1): e70191-e70191 被引量:4
标识
DOI:10.1002/ctm2.70191
摘要

BACKGROUND: Vitamin K-dependent γ-glutamic acid carboxylation (Gla) proteins are calcium-binding and membrane-associated, participating in coagulation, bone turnover, and cancer biology. The molecular function of transmembrane proline-rich Gla proteins (PRRGs) remains unexplored. METHODS: Analysis of pancreatic ductal adenocarcinoma (PDAC) datasets, including transcription profiles, clinical data, and tissue microarrays, was conducted to evaluate PRRG1 expression and its clinical relevance. PDAC cell lines with overexpressed, knockdown, and mutated PRRG1 were developed to study biological functions and pathways using RNA-seq, co-immunoprecipitation with mass spectrometry, Western blotting, and immunofluorescence. In vivo xenograft and orthotopic models assessed PRRG1's impact on PDAC progression, with and without warfarin treatment. RESULTS: PRRG1 was significantly upregulated in PDAC compared to normal pancreas, correlating with poorer patient survival. PRRG1 knockdown reduced PDAC cell proliferation, anchorage-independent growth in vitro, and tumor growth in vivo. PRRG1 localized at the plasma membrane, interacted with the HECT E3 ligase NEDD4 via the C-terminal PPXY motif, and promoted NEDD4 self-ubiquitination, reducing its protein levels. PRRG1 knockdown elevated NEDD4, destabilizing the oncoprotein KRAS and receptor EGFR, and attenuating downstream signaling and macropinocytosis under nutrient deprivation. The vitamin K-dependent Gla modification of PRRG1 was crucial for its membrane localization and pro-tumorigenic effects, and was inhibited by low-dose warfarin, a clinical vitamin K antagonist. CONCLUSIONS: This study identifies PRRG1 as a key regulator of pro-tumorigenic signaling in PDAC, suggesting the potential of repurposing the anticoagulant warfarin as a therapeutic strategy. KEY POINTS: PRRG1 is identified as the transmembrane Gla protein mediating PDAC malignancy. PRRG1 recruits and induces self-ubiquitination of membrane-anchoring E3 ligase NEDD4. PRRG1 exerts a protective role toward KRAS and EGFR by inhibiting NEDD4. The anticoagulant warfarin can be utilized to inhibit PRRG1 and PDAC advancement.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
sunshiny完成签到,获得积分10
1秒前
王白石发布了新的文献求助10
1秒前
李晨语完成签到,获得积分10
1秒前
酱啊油完成签到,获得积分10
1秒前
风吹麦浪的应助被1234567采纳,获得10
2秒前
xiaoxiaoshu完成签到,获得积分10
2秒前
2秒前
领导范儿的应助被1234567采纳,获得10
2秒前
Ava的应助被111采纳,获得10
2秒前
糖淘淘完成签到,获得积分10
2秒前
3秒前
yuliuism发布了新的文献求助10
3秒前
4秒前
6秒前
xiaocao发布了新的文献求助10
6秒前
闪闪凝梦发布了新的文献求助20
6秒前
JamesPei的应助被zhikaiyici采纳,获得30
6秒前
7秒前
钟梓袄发布了新的文献求助10
7秒前
7秒前
现实的无心完成签到 ,获得积分10
8秒前
nissy完成签到,获得积分10
9秒前
10秒前
草莓软糖发布了新的文献求助10
10秒前
zhl发布了新的文献求助10
10秒前
10秒前
奋斗土豆完成签到 ,获得积分10
10秒前
Maestro_S的应助被fhtdt采纳,获得10
11秒前
在水一方的应助被Jennie369采纳,获得30
11秒前
12秒前
12秒前
12秒前
华仔的应助被n11采纳,获得10
13秒前
whisper完成签到,获得积分10
13秒前
爆米花的应助被清辉影采纳,获得30
13秒前
AAA建材王哥完成签到,获得积分10
13秒前
13秒前
大个的应助被123采纳,获得10
14秒前
14秒前
14秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183204
求助须知:如何正确求助?哪些是违规求助? 9572434
关于积分的说明 21825655
捐赠科研通 7779988
什么是DOI,文献DOI怎么找? 3433852
关于科研通互助平台的介绍 2558060
邀请新用户注册赠送积分活动 2480148